Work

Changes in Long-acting β-agonist Utilization After the FDA’s 2010 Drug Safety Communication

Year: 2014

Type: article

Study design: Observational Study

Source: Clinical Therapeutics

DOI: 10.1016/j.clinthera.2014.10.025

Authors: Daniel M. Hartung, Luke Middleton, Sheila Markwardt, Kaylee Williamson, Kathy Ketchum

Institutions: Oregon State University, Oregon Health & Science University

Language: English

Topic: Pharmacovigilance and Adverse Drug Reactions

Subfield: Toxicology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Agency for Healthcare Research and Quality

Award: G1638496813

OpenAlex ID: W2080654393

FWCI: 1.242

Cites: 28

Cited by: 8

Related to: 10